April 12, 2024

The Rising Applications of Gene Cloning Drive the Demand for Electrocompetent Cells Market

The global electrocompetent cells market is estimated to be valued at US$ 2.07 Bn in 2024 and is expected to exhibit a CAGR of 10.% over the forecast period 2023 to 2030. Electrocompetent cells, also known as electroporation competent cells, are transformed or transfected by electroporation. Electroporation involves applying high-voltage electric pulses to bacterial cells, which result in the creation of transient pores in the cell membrane. These pores allow exogenous DNA such as plasmids to enter the cell. Electrocompetent cells have advantages like high transformation efficiency, convenience and rapidity. They are widely used during plasmid preparation and in site-directed mutagenesis, protein expression, sequencing and protein engineering.

Key Takeaways

Key players operating in the electrocompetent cells market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies, Inc., QIAGEN N.V., New England Biolabs, Inc., GenScript Biotech Corporation, Lucigen Corporation, Takara Bio Inc., Delphi Genetics S.A., IBA GmbH, Scarab Genomics LLC, Zymo Research Corporation, Bioline GmbH. Key players like Thermo Fisher Scientific Inc. and Merck KGaA dominate the market with their diverse product portfolio and strong global distribution network.

The growing demand for electrocompetent cells is attributed to the rising applications of gene cloning and gene modification techniques across various sectors like biotechnology, pharma, healthcare and academic research. Additionally, expanding genomics research activities and investments in the development of novel therapeutic systems are fueling market growth.

The global electrocompetent cells market is witnessing expansion into emerging economies of Asia Pacific and Latin America. This is due to increasing R&D expenditures, growth of CROs and pharmaceutical industry and rising awareness about advanced cell biology research techniques in these regions. Moreover, strategic collaborations between global players and regional research institutions are supporting technology transfer and market penetration.

Market Key Trends

A key trend gaining traction in the electrocompetent cells market is the development of specialized cell lines with enhanced transformation efficiencies for distinct gene cloning applications. For example, DH5α and DH10B electrocompetent cells are commonly used for routine cloning experiments whereas cell lines like XL10-Gold and Stbl3 offer higher stability for maintaining cloning vectors. Additionally, innovations focused on generating electrocompetent cell variants compatible with modern genome editing techniques like CRISPR-Cas9 will further expand the scope of gene manipulation research.

Porter’s Analysis
Threat of new entrants: Low market entry barrier as manufacturing process is relatively simple; however,established players dominate the market through patents,brand image, and distribution network.

Bargaining power of buyers: Moderate as buyers have limited options and suppliers have product differentiation; however,availability of substitutes provide options to buyers.

Bargaining power of suppliers: High as key raw materials and manufacturing process expertise is concentrated among few suppliers globally.

Threat of new substitutes: Low as electrocompetent cells have well-established applications in cloning and protein expression with no close substitutes.

Competitive rivalry: Intense as top players compete on quality, yield, customization and technical support to gain market share.

North America accounts for the largest share of the electrocompetent cells market due to increasing investments in life sciences R&D. The presence of global leaders and availability of required infrastructure and skilled workforce further support market growth.

Asia Pacific electrocompetent cells market is poised to witness the fastest growth over the forecast period supported by expanding biologics manufacturing capabilities,rising proteomics research and increasing foreign investments in China,India and South Korea. Growing academic-industry collaboration and rising disease burden will augment the regional market.

*Note:

  1. Source: Coherent Market Insights, Public sources, Desk research
  2. We have leveraged AI tools to mine information and compile it